Published in Proc Natl Acad Sci U S A on October 01, 1984
A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis. Lipids Health Dis (2016) 1.38
Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest (1986) 1.28
A new method for sequencing DNA. Proc Natl Acad Sci U S A (1977) 250.51
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Reversal of bacteriophage T4 induced polynucleotide kinase action. Biochemistry (1973) 21.41
Plasmid screening at high colony density. Gene (1980) 16.47
The use of synthetic oligonucleotides as hybridization probes. II. Hybridization of oligonucleotides of mixed sequence to rabbit beta-globin DNA. Nucleic Acids Res (1981) 9.56
Filter replicas and permanent collections of recombinant DNA plasmids. Nucleic Acids Res (1979) 8.00
Signal recognition particle contains a 7S RNA essential for protein translocation across the endoplasmic reticulum. Nature (1982) 7.80
Isolation of beta-globin-related genes from a human cosmid library. Gene (1981) 5.97
Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40
Post-translational proteolysis in polypeptide hormone biosynthesis. Annu Rev Physiol (1982) 3.43
Chemical synthesis of deoxyoligonucleotides by the modified triester method. Methods Enzymol (1980) 3.23
Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med (1978) 2.92
A specific apoprotein activator for lipoprotein lipase. Biochem Biophys Res Commun (1970) 2.24
Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J Biol Chem (1979) 2.00
Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII. Proc Natl Acad Sci U S A (1984) 1.91
Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease. Proc Natl Acad Sci U S A (1984) 1.86
The plasma lipoproteins. Adv Protein Chem (1977) 1.65
Predicted secondary structures of amino-terminal extension sequences of secreted proteins. FEBS Lett (1979) 1.60
On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. Biochim Biophys Acta (1973) 1.59
The plasma lipoproteins: structure and metabolism. Annu Rev Biochem (1978) 1.54
Role of specific glycopeptides of human serum lipoproteins in the activation of lipoprotein lipase. Circ Res (1970) 1.52
The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man. Hum Genet (1982) 1.40
Combined deficiency of apolipoprotein C-II and lipoprotein lipase in familial hyperchylomicronemia. Metabolism (1981) 1.26
Intracellular and extracellular processing of human apolipoprotein A-I: secreted apolipoprotein A-I isoprotein 2 is a propeptide. Proc Natl Acad Sci U S A (1983) 1.16
Primary structure of very low density apolipoprotein C-II of human plasma. Proc Natl Acad Sci U S A (1977) 1.16
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion. Eur J Clin Invest (1981) 1.14
In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity. J Biol Chem (1983) 1.10
Biosynthesis of human preproapolipoprotein A-II. J Biol Chem (1983) 1.10
Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis (1979) 1.09
cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I. Biochem Biophys Res Commun (1983) 1.07
Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA. Proc Natl Acad Sci U S A (1984) 1.06
Amino acid sequence of human plasma apolipoprotein C-II from normal and hyperlipoproteinemic subjects. J Biol Chem (1984) 1.04
Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier. J Biol Chem (1984) 0.91
The localization of the gene for apolipoprotein C-II to chromosome 19. Biochem Biophys Res Commun (1984) 0.90
Biosynthesis of human preapolipoprotein A-IV. J Biol Chem (1984) 0.90
Plasma lipids, lipoproteins and apoproteins in a case of apo C-II deficiency. Clin Chim Acta (1983) 0.88
Biosynthesis of apolipoprotein C-III in rat liver and small intestinal mucosa. J Biol Chem (1984) 0.78
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat Genet (1999) 7.04
Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature (1994) 4.28
PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med (2001) 4.17
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Advances in the gas chromatographic analysis of amino acid phenyl- and methylthiohydantoins. Anal Biochem (1972) 2.56
Human apolipoprotein B-100: cloning, analysis of liver mRNA, and assignment of the gene to chromosome 2. Proc Natl Acad Sci U S A (1985) 2.53
Homology between the primary structure of alpha-fetoprotein, deduced from a complete cDNA sequence, and serum albumin. Nature (1981) 2.37
Nucleotide sequence and the encoded amino acids of human serum albumin mRNA. Proc Natl Acad Sci U S A (1982) 2.26
Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem (2001) 2.26
Bovine parathyroid hormone: amino acid sequence. Proc Natl Acad Sci U S A (1970) 2.08
Two genes that map to the STSL locus cause sitosterolemia: genomic structure and spectrum of mutations involving sterolin-1 and sterolin-2, encoded by ABCG5 and ABCG8, respectively. Am J Hum Genet (2001) 2.08
Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol (1984) 1.99
Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest (1986) 1.98
Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun (2001) 1.91
Familial apolipoprotein E deficiency. J Clin Invest (1986) 1.87
The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins. Biochem Biophys Res Commun (1978) 1.75
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics (1990) 1.74
Quantitation of plasma apolipoproteins in the primary and secondary prevention of coronary artery disease. Ann Intern Med (1994) 1.70
Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex. Proc Natl Acad Sci U S A (1972) 1.68
The plasma lipoproteins. Adv Protein Chem (1977) 1.65
ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice. J Clin Invest (2001) 1.61
Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis (1982) 1.57
Swine lipoproteins and atherosclerosis. Changes in the plasma lipoproteins and apoproteins induced by cholesterol feeding. Biochemistry (1975) 1.50
Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med (1993) 1.50
High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase. Nat Med (1997) 1.48
Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun (1980) 1.46
Abnormal metabolism of shellfish sterols in a patient with sitosterolemia and xanthomatosis. J Clin Invest (1986) 1.46
A prospective case-control study of ankle fracture in postmenopausal women. Hong Kong Med J (2006) 1.46
Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred. Proc Natl Acad Sci U S A (1999) 1.42
Human liver apolipoprotein B-100 cDNA: complete nucleic acid and derived amino acid sequence. Proc Natl Acad Sci U S A (1986) 1.42
Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease). Ann Intern Med (1980) 1.41
NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med (1983) 1.36
Isolation and characterization of apoLp-Gln-II (apoA-II), a plasma high density apolipoprotein containing two identical polypeptide chains. J Biol Chem (1972) 1.36
3-Hydroxy-3-methylglutaryl coenzyme A reductase: regulation of enzymatic activity by phosphorylation and dephosphorylation. Proc Natl Acad Sci U S A (1978) 1.34
Isolation and characterization of apolipoproteins A-I, A-II, and A-IV. Methods Enzymol (1986) 1.34
Human chylomicron apolipoprotein metabolism. Biochem Biophys Res Commun (1978) 1.34
Identification of two mPPAR related receptors and evidence for the existence of five subfamily members. Biochem Biophys Res Commun (1993) 1.32
Decreased reverse cholesterol transport from Tangier disease fibroblasts. Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol (1997) 1.32
Human apolipoprotein A-I and A-II metabolism. J Lipid Res (1982) 1.32
The amino acid sequence of porcine thyrocalcitonin. Proc Natl Acad Sci U S A (1968) 1.31
Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science (1981) 1.29
Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci U S A (1996) 1.27
Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci U S A (2000) 1.26
Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. Mol Endocrinol (1994) 1.26
The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism (1985) 1.23
Metabolism of high-density lipoprotein apolipoproteins in Tangier disease. N Engl J Med (1978) 1.23
Human parathyroid hormone: amino-acid sequence of the amino-terminal residues 1-34. Proc Natl Acad Sci U S A (1972) 1.22
The effects of estrogen administration on plasma lipoprotein metabolism in premenopausal females. J Clin Endocrinol Metab (1983) 1.22
The complete amino acid sequence of alanine apolipoprotein (apoC-3), and apolipoprotein from human plasma very low density lipoproteins. J Biol Chem (1974) 1.22
Adrenal cholesterol uptake from plasma lipoproteins: regulation by corticotropin. Proc Natl Acad Sci U S A (1976) 1.21
Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice. J Biol Chem (1999) 1.21
Analysis of glomerulosclerosis and atherosclerosis in lecithin cholesterol acyltransferase-deficient mice. J Biol Chem (2001) 1.21
Increased prevalence of apolipoprotein E4 in type V hyperlipoproteinemia. J Clin Invest (1982) 1.20
Regulation of liver 3-hydroxy-3-methylglutaryl-CoA reductase. Curr Top Cell Regul (1981) 1.20
Characterization of hepatic low density lipoprotein binding and cholesterol metabolism in normal and homozygous familial hypercholesterolemic subjects. J Clin Invest (1984) 1.18
Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis. Proc Natl Acad Sci U S A (1999) 1.18
Inhibition of rat sexual behavior by antisense oligonucleotides to the progesterone receptor. Endocrinology (1994) 1.18
Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest (1993) 1.17
3-Hydroxy-3-methylglutaryl--coenzyme A reductase inhibitors in the treatment of hypercholesterolemia. JAMA (1987) 1.17
Lipid-protein interactions in high density lipoproteins. Proc Natl Acad Sci U S A (1974) 1.17
Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem (1984) 1.17
Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency. Am J Hum Genet (1984) 1.15
New micromethod for measuring cholesterol in plasma lipoprotein fractions. Clin Chem (1977) 1.15
The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest (1994) 1.14
Plasma-triglycerides in regulation of H.D.L.-cholesterol levels. Lancet (1978) 1.13
Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem (1997) 1.13
Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia. J Clin Invest (1986) 1.13
Identification of a novel in-frame translational stop codon in human intestine apoB mRNA. Biochem Biophys Res Commun (1987) 1.13
Apolipoprotein EBethesda: a new variant of apolipoprotein E associated with type III hyperlipoproteinemia. J Clin Endocrinol Metab (1983) 1.13
The molecular biology of human apoA-I, apoA-II, apoC-II and apoB. Adv Exp Med Biol (1986) 1.12
Enhanced soft tissue repair using locking loop stitch after posterior approach for hip hemiarthroplasty. J Arthroplasty (2001) 1.12
Effect of gangliosides and substrate analogues on the hydrolysis of nicotinamide adenine dinucleotide by choleragen. Proc Natl Acad Sci U S A (1977) 1.11
Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology (1985) 1.11
Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci (2001) 1.10
Human apolipoprotein B (apoB) mRNA: identification of two distinct apoB mRNAs, an mRNA with the apoB-100 sequence and an apoB mRNA containing a premature in-frame translational stop codon, in both liver and intestine. Proc Natl Acad Sci U S A (1988) 1.09
The rate of molecular evolution of alpha-fetoprotein approaches that of pseudogenes. Mol Biol Evol (1985) 1.08
Targeted disruption of the mouse lecithin:cholesterol acyltransferase (LCAT) gene. Generation of a new animal model for human LCAT deficiency. J Biol Chem (1997) 1.08
Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II. J Intern Med (1992) 1.08
In vivo metabolism of a mutant apolipoprotein, apoA-IIowa, associated with hypoalphalipoproteinemia and hereditary systemic amyloidosis. J Lipid Res (1992) 1.08
Purification and characterization of 3-hydroxy-3-methylglutaryl coenzyme A reductase from chicken liver. FEBS Lett (1977) 1.08
cDNA cloning of human apoA-I: amino acid sequence of preproapoA-I. Biochem Biophys Res Commun (1983) 1.07
A deletion mutation in the ApoC-II gene (ApoC-II Nijmegen) of a patient with a deficiency of apolipoprotein C-II. J Biol Chem (1988) 1.07
In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II. J Lipid Res (1991) 1.06
Circulatory, plasma catecholamine, cortisol, lipid, and psychological responses to a real-life stress (third molar extractions): effects of diazepam sedation and of inclusion of epinephrine with the local anesthetic. Psychosom Med (1982) 1.06
Human apolipoprotein A-I and C-III genes reside in the p11----q13 region of chromosome 11. Biochem Biophys Res Commun (1984) 1.06
Nucleotide sequence and the encoded amino acids of human apolipoprotein A-I mRNA. Proc Natl Acad Sci U S A (1984) 1.06
Structural studies on rabbit muscle glycogen synthase. I. Subunit composition. J Biol Chem (1975) 1.06
Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. Metabolism (1987) 1.06
Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest (1995) 1.05
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment. Atherosclerosis (1985) 1.05